Molecular Imaging: Page 2

PET/MRI detects ‘unknown’ generators of musculoskeletal pain
By Will Morton
Potential pain generators were identified by increased F-18 FDG radiotracer uptake on PET and/or structural abnormalities on MRI.
December 5, 2025
Back Pain 400
Eckert & Ziegler to supply SK Biopharmaceuticals with actinium-225
By AuntMinnieEurope.com staff writers
SK Biopharmaceuticals has signed an agreement with Eckert & Ziegler to provide actinium-225 (Ac-225) to accelerate R & D in radiopharmaceutical therapies.
December 4, 2025
Atom Nuclear Lab 400
IAEA recommends global adoption of PSMA-PET
By Will Morton
A global trial sponsored by the International Atomic Energy Agency (IAEA) supports the adoption of prostate-specific antigen (PSMA) PET/CT into standard staging protocols.
November 18, 2025
2025 11 14 Iaea Recommends Psma Pet Thumbnail
PSMA-PET effective for initial staging of prostate cancer
By Will Morton
Researchers from Bonn, Germany, have found that upfront PSMA-PET/CT has a major impact on treatment decision-making in suspected cases of prostate cancer.
November 14, 2025
2025 11 10 Psma Pet Phase Ii Trial Thumbnail
Nuclear medicine societies launch theranostics consortium
By AuntMinnieEurope.com staff writers
Four nuclear medicine societies have collaborated to establish a consortium that seeks to advance theranostics care.
October 31, 2025
Nuclear Medicine Gamma Camera 400 (1)
LLMs rapidly evolving in nuclear medicine
By Will Morton
Large language models (LLMs) are widely used to handle the large volume of text data generated in nuclear medicine.
October 27, 2025
Artificial Intelligence Ai Hand 400
PET/MRI begins to deliver in breast cancer
By Philip Ward
The clinical role of PET/MRI is evolving rapidly in breast cancer, according to two studies presented at the European Society of Breast Imaging annual meeting.
October 23, 2025
Dedicated breast F-18 FDG PET/MRI exam pre- (A, D, G), mid- (B, E, H), and post-NAC (C, F, I) of a 41-year-old patient diagnosed with a triple negative (TN), grade 2, invasive carcinoma. The SUVmax values of the primary tumor were 14.68 pre-NAC, 1.69 mid-NAC, and 1.87 post-NAC, while SER values were 1.19, 0.52, and 0.63, respectively. Figure courtesy of Melissa Lenaerts, PhD, Dr. Thiemo van Nijnatten, PhD, et al and presented at EUSOBI 2025.
EUSOBI: Positron emission mammography demonstrates worth
By Edna Astbury-Ward, PhD
Positron emission mammography is proving useful in the presurgical assessment of invasive lobular carcinoma, researchers reported at the European Society of Breast Imaging (EUSOBI) annual meeting.
October 22, 2025
A 399 Fig 2 Pem Vs Cesm E Poster Eusobi 2025 Deabes Thumbnail
Amyloid PET can track patterns of neurodegeneration
By Maryam Payne
Early perfusion amyloid-PET shows potential for diagnosing and monitoring neurodegenerative disease and has possible advantages over FDG-PET scanning.
October 22, 2025
2025 10 20 Eanm Early Perfusion Imaging Fig1 Thumbnail
PSMA-PET/CT may replace NaF-PET/CT in advanced prostate cancer
By Will Morton
Replacing F-18 sodium fluoride (NaF) PET/CT with F-18 PSMA PET/CT can improve treatment for men with newly diagnosed prostate cancer.
October 13, 2025
2025 10 09 Jnumed Psma Pet Vs Na F Pet Thumbnail
Will AI lead to merger of radiology and pathology?
By Edna Astbury-Ward, PhD
A strategic merger of radiology and pathology into a unified specialty is vital, two experts have warned in an 8 October commentary in European Journal of Radiology AI.
October 9, 2025
Glowing Neon Skeleton Nervous System Adobe Yuliia
GLP-1 drugs may confound PET/CT imaging findings
By AuntMinnieEurope.com staff writers
GLP-1 receptor agonists may affect the interpretation of oncological FDG PET/CT scans, according to research presented at the annual meeting of the European Association of Nuclear Medicine.
October 8, 2025
Semaglutide Injection Pen
Previous Page
Page 2 of 124
Next Page